John Buse, MDEnriched profile
Verne S. Caviness Distinguished Professor of Medicine; Chief, Division of Endocrinology and Metabolism; Director, UNC Diabetes Center; Director, NC Translational and Clinical Sciences Institute; Executive Associate Dean for Clinical Research · University of North Carolina School of Medicine
Overview
Updated 14 Jul 2026
John Buse, MD, is Verne S. Caviness Distinguished Professor of Medicine at University of North Carolina School of Medicine. The public record shows 1,053 publications with 112,874 citations (h-index 141), centered on Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 15 companies, 7 NIH-funded awards (1997–2023).
- Most recent indexed publication: 2026 · Diabetes care
- Top research focus: Diabetes Treatment and Management
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 108 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 492.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- Deputy Editor
Diabetes Care (American Diabetes Association journal)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesjournals.org ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Sponsor: GentiBio, Inc
InvestigatorPhase 1RecruitingNCT06919354 - Rare and Atypical Diabetes Network
Sponsor: University of South Florida
InvestigatorRecruitingNCT05544266 - The Insulin-Only Bionic Pancreas Pivotal Trial
Sponsor: Jaeb Center for Health Research
InvestigatorCompletedNCT04200313
Industry payments
Updated 14 Jul 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year202510 payments$25,029openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202513 payments$16,616openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20253 payments$11,514openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
7 NIH research awards on record, funded 1997–2023 per NIH RePORTER. The latest:
- North Carolina Translational and Clinical Sciences Institute (NC TraCS)
Univ of North Carolina Chapel Hill
FY2023$10,042,058UM1TR004406 - North Carolina Translational and Clinical Science Institute (NC TraCS)
Univ of North Carolina Chapel Hill
FY2022$9,945,630UL1TR002489 - North Carolina Translational and Clinical Science Institute (NC TraCS)
Univ of North Carolina Chapel Hill
FY2022$218,324UL1TR002489
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials.
Diabetes, obesity & metabolism
2026 - GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women.
JCO oncology practice
2026
Most-cited worksby citation count (OpenAlex)
- 01Effects of Intensive Glucose Lowering in Type 2 Diabetes7,899 citations2008
- 02Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes7,395 citations2016
- 04
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
8025 Burnett Womack Building, Campus Box #7172, Chapel Hill, NC 27599-7170
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- BA
Biochemistry, Dartmouth College
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - MD
Duke University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - PhD
Duke University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Internal Medicine Internship and Residency
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Endocrinology Fellowship
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Editorial & leadership rolesjournal and society appointments
- Chief
Division of Endocrinology and Metabolism, UNC School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Director
UNC Diabetes Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Director
NC Translational and Clinical Sciences Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →professional.diabetes.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →professional.diabetes.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unchealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviewspress, podcasts and appearances
- Podcast: "The Story Behind the 'Miracle' of GLP-1 Medications"
Raise the Line, Oct 28, 2025 (Episode 551)
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - HCPLive Endocrinology podcast segment on CATALYST Trial
Mifepristone, and Hypercortisolism in Type 2 Diabetes, recorded at ADA 2025
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗ - "Diabetes Discussion with Dr. John Buse"
UNC Department of Medicine podcast
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/john-buse-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
med.unc.edu/medicine/endocrinology-metabolism/people/john-buse-md-phd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Other
ncbi.nlm.nih.gov/myncbi/john%20b.buse.1/bibliography/public
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ncbi.nlm.nih.gov ↗
Mentions by otherswhere others cite or feature them
- Other
music.amazon.com/podcasts/dfe4cd1a-2f96-4edc-ade2-2c6c70072a82/episodes/213f12c2-6356-46ca-9bc8-6807b85301cd/raise-the-line-the-story-behind-the-%E2%80%98miracle%E2%80%99-of-glp-1-medications-dr-john-buse-chief-of-endocrinology-at-university-of-north-carolina-school-of-medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →music.amazon.com ↗ - Other
med.unc.edu/medicine/news/chairs-corner/podcast/diabetes-care
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
Universitair Ziekenhuis Leuven
- 1,845
- publications
- 177
- h-index
- 14
- trials
Josep Tabernero, MD, PhD
Vall d'Hebron Institut de Recerca
- 2,704
- publications
- 148
- h-index
- 19
- trials
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
- 1,745
- publications
- 154
- h-index
- 22
- trials
Charles Fuchs, MD, MPH
Yale Cancer Center
- 1,721
- publications
- 172
- h-index
- 7
- trials